Home | Business News | CBJ Newsmakers | Tetra Bio-Pharma and Altus Formulation Sign Joint Venture Agreement for Cannabinoid Drug Product Development Tetra Bio-Pharma and Altus Formulation Sign Joint Venture Agreement for Cannabinoid Drug Product Development RecommendedValour Inc. Announces Change of AuditorReal Estate Split Corp. Establishes At-The-Market Equity ProgramLeonovus Announces Bridge Loan
